Leerink Partners Forecasts Strong Price Appreciation for Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare (NYSE:THC) had its target price raised by equities researchers at Leerink Partners from $255.00 to $264.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Leerink Partners’ target price would indicate a potential upside of 15.00% from the company’s current price.

Other research analysts have also issued reports about the stock. Barclays raised their target price on shares of Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a research note on Friday, February 13th. Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 31st. UBS Group upped their target price on Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a report on Thursday, February 12th. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $260.00 price objective on shares of Tenet Healthcare in a report on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and an average target price of $247.67.

Tenet Healthcare Stock Performance

NYSE THC opened at $229.56 on Friday. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. Tenet Healthcare has a 1-year low of $109.82 and a 1-year high of $235.77. The company has a market cap of $19.96 billion, a PE ratio of 14.82, a price-to-earnings-growth ratio of 1.13 and a beta of 1.44. The stock’s 50 day simple moving average is $201.87 and its 200-day simple moving average is $197.42.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s quarterly revenue was up 8.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities research analysts anticipate that Tenet Healthcare will post 12.24 EPS for the current fiscal year.

Insider Activity at Tenet Healthcare

In related news, Director Nadja West sold 2,178 shares of the stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the transaction, the director owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.81% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. AlphaQuest LLC boosted its holdings in Tenet Healthcare by 230.8% in the second quarter. AlphaQuest LLC now owns 1,763 shares of the company’s stock valued at $310,000 after purchasing an additional 1,230 shares during the period. WCM Investment Management LLC raised its position in Tenet Healthcare by 244.4% in the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock valued at $102,657,000 after purchasing an additional 362,083 shares in the last quarter. Winnow Wealth LLC acquired a new position in shares of Tenet Healthcare during the third quarter worth about $1,129,000. Cerity Partners LLC increased its stake in shares of Tenet Healthcare by 10.4% during the second quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock worth $21,230,000 after buying an additional 11,395 shares during the period. Finally, Savant Capital LLC raised its holdings in Tenet Healthcare by 27.5% in the third quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock valued at $3,430,000 after acquiring an additional 3,647 shares in the last quarter. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.